Kala Bio (KALA) Inventory Average (2018 - 2022)
Kala Bio's (KALA) quarterly Inventory Average came in at $5.3 million in Q2 2022, down 35.19% year-over-year from $8.1 million in Q2 2021, and down 44.93% quarter-over-quarter from $9.6 million in Q1 2022.
Analysis
Kala Bio (KALA) Inventory Average (2018 - 2022) Analysis & Trends
Kala Bio has disclosed Inventory Average across 5 years of filings, most recently posting $5.3 million for Q2 2022.
- In Q2 2022, Inventory Average fell 35.19% year-over-year to $5.3 million; the TTM figure through Jun 2022 stood at $5.3 million (down 35.19% YoY), while the FY2021 annual figure was $6.9 million, up 40.41% from the prior year.
- Inventory Average came in at $5.3 million for Q2 2022 at Kala Bio, down from $9.6 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $9.6 million in Q1 2022 to a low of $2.5 million in Q4 2018.
- Average Inventory Average over 5 years is $6.4 million, with a median of $6.6 million recorded in 2020.
- Year-over-year, Inventory Average soared 101.24% in 2019 and slumped 35.19% in 2022.
- Over 5 years, Inventory Average stood at $2.5 million in 2018, then soared by 101.24% to $5.1 million in 2019, then rose by 25.11% to $6.4 million in 2020, then advanced by 28.04% to $8.2 million in 2021, then plunged by 35.43% to $5.3 million in 2022.
- Per Business Quant data, the three most recent Inventory Average figures were $5.3 million in Q2 2022, $9.6 million in Q1 2022, and $8.2 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.55 Bn | 192.56 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 180.15 Bn | 176.98 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 131.59 Bn | 123.73 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 81.98 Bn | 73.98 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 60.33 Bn | 55.14 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.75 Bn | 48.61 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.06 Bn | 29.76 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.95 Bn | 30.67 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | - |
| 10 | Kala Bio | 8.44 Mn | 8.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 5.28 Mn |
| Mar 31, 2022 | 9.59 Mn |
| Dec 31, 2021 | 8.17 Mn |
| Sep 30, 2021 | 7.88 Mn |
| Jun 30, 2021 | 8.14 Mn |
| Mar 31, 2021 | 6.74 Mn |
| Dec 31, 2020 | 6.38 Mn |
| Sep 30, 2020 | 6.62 Mn |
| Jun 30, 2020 | 5.49 Mn |
| Mar 31, 2020 | 4.96 Mn |
| Dec 31, 2019 | 5.10 Mn |
| Sep 30, 2019 | 6.89 Mn |
| Jun 30, 2019 | 6.82 Mn |
| Mar 31, 2019 | 4.76 Mn |
| Dec 31, 2018 | 2.54 Mn |